TDP-43 Pathology, Cognitive Decline, and Dementia in Old Age

被引:189
|
作者
Wilson, Robert S. [1 ]
Yu, Lei [1 ]
Trojanowski, John Q. [2 ]
Chen, Er-Yun [1 ]
Boyle, Patricia A. [1 ]
Bennett, David A. [1 ]
Schneider, Julie A. [1 ]
机构
[1] Rush Univ, Univ Ctr, Rush Alzheimers Dis Ctr, Dept Neurol Sci Behav Sci & Pathol, Chicago, IL 60612 USA
[2] Univ Penn, Dept Pathol & Lab Med, Inst Aging Ctr Neurodegenerat Dis Res, Philadelphia, PA USA
关键词
FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; ALZHEIMERS-DISEASE; HIPPOCAMPAL SCLEROSIS; LEWY BODIES; IMPAIRMENT; ASSOCIATION; IMMUNOREACTIVITY; CONSORTIUM; INCLUSIONS;
D O I
10.1001/jamaneurol.2013.3961
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IMPORTANCE Cognitive decline is a leading cause of disability and death in old age but its neurobiological bases are not well understood. OBJECTIVE To test the hypothesis that transactive response DNA-binding protein 43 (TDP-43) is related to late-life cognitive decline. DESIGN, SETTING, AND PARTICIPANTS Longitudinal clinical-pathologic cohort study involving more than 40 Catholic groups across the United States. A total of 130 older Catholic nuns, priests, and monks underwent annual clinical evaluations, including detailed cognitive testing, for a mean of 10.1 years prior to death. On neuropathologic examination, we collected semiquantitative measures of TDP-43 pathology, density of neuronal neurofibrillary tangles, area occupied by amyloid-beta plaques, and the presence of alpha-synuclein Lewy bodies from multiple brain regions. Gross and microscopic cerebral infarcts and hippocampal sclerosis were also identified. MAIN OUTCOMES AND MEASURES Annual rate of change in a previously established composite measure of global cognition during a mean of 10.1 years of annual observation before death. RESULTS Transactive response DNA-binding protein 43 pathology, ranging from sparse to severe, was identified in 46% of participants and was associated with amyloid plaques, tangles, and hippocampal sclerosis but not neocortical Lewy bodies or cerebral infarcts. After controlling for amyloid plaques, tangles, and hippocampal sclerosis, TDP-43 pathology was associated with more rapid cognitive decline and accounted for nearly as much of the variability in rates of global cognitive decline as did tangles. Transactive response DNA-binding protein 43 pathology had a distinct cognitive profile that differed from other neuropathologic processes (related to decline in episodic and working memory but not in other cognitive domains), and it was elevated in those who developed dementia but not in those with mild cognitive impairment. CONCLUSION AND RELEVANCE The results suggest that TDP-43 is an important brain pathology underlying cognitive decline and dementia in old age.
引用
收藏
页码:1418 / 1424
页数:7
相关论文
共 50 条
  • [31] TDP-43 pathology in FTLD-subtypes
    Nishihira, Yasushi
    Mao, Qinwen
    Kohler, Missia
    Coppola, Giovanni
    Rademakers, Rosa
    Rademaker, Alfred
    Weintraub, Sandra
    Mesula, M-Marsel
    Geula, Changiz
    Bigio, Eileen H.
    BRAIN PATHOLOGY, 2019, 29 : 80 - 80
  • [32] TDP-43 Pathology in Alzheimer’s Disease
    Axel Meneses
    Shunsuke Koga
    Justin O’Leary
    Dennis W. Dickson
    Guojun Bu
    Na Zhao
    Molecular Neurodegeneration, 16
  • [33] No association of TDP-43 with sporadic frontotemporal dementia
    Schumacher, Axel
    Friedrich, Patricia
    Diehl-Schmid, Janine
    Ibach, Bernd
    Perneczky, Robert
    Eisele, Tamara
    Vukovich, Ruth
    Foerstl, Hans
    Riemenschneider, Matthias
    NEUROBIOLOGY OF AGING, 2009, 30 (01) : 157 - 159
  • [34] TDP-43 pathology in subacute sclerosing panencephalitis
    Acewicz, Albert
    Stepien, Tomasz
    Grzegorczyk, Michal
    Ostrowski, Robert P.
    Tarka, Sylwia
    Felczak, Paulina
    Wierzba-Bobrowicz, Teresa
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (04): : 251 - 257
  • [35] IDENTIFICATION OF BIOFLUID MARKERS OF TDP-43 PATHOLOGY
    Rachelle, Shafei
    Martha, Foiani
    Carolin, Heller
    Amanda, Heslegrave
    Ione, Woollacott
    Katrina, Dick
    Jason, Warren
    Jonathan, Schott
    Henrik, Zetterberg
    Jonathan, Rohrer
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
  • [36] TDP-43 Pathology in Alzheimer's Disease
    Meneses, Axel
    Koga, Shunsuke
    O'Leary, Justin
    Dickson, Dennis W.
    Bu, Guojun
    Zhao, Na
    MOLECULAR NEURODEGENERATION, 2021, 16 (01)
  • [37] Brain mural cell loss in the parietal cortex in Alzheimer's disease correlates with cognitive decline and TDP-43 pathology
    Bourassa, P.
    Tremblay, C.
    Schneider, J. A.
    Bennett, D. A.
    Calon, F.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2020, 46 (05) : 458 - 477
  • [38] Astrocytic TDP-43 Pathology in Alexander Disease
    Walker, Adam K.
    Daniels, Christine M. LaPash
    Goldman, James E.
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    Messing, Albee
    JOURNAL OF NEUROSCIENCE, 2014, 34 (19): : 6448 - 6458
  • [39] TDP-43 pathology in primary lateral sclerosis
    Mackenzie, Ian R. A.
    Briemberg, Hannah
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2020, 21 : 52 - 58
  • [40] New mechanistic insights into TDP-43 pathology
    Heather Wood
    Nature Reviews Neurology, 2023, 19 : 574 - 574